Press release
Duchenne Muscular Dystrophy Market: Promising Growth, Key Drivers and Current Trends Tracing a forecasted CAGR of 8.9% & 8.5% respectively in 2024-25 and 2025-29 periods.
Duchenne Muscular Dystrophy Market
What Is The Projected Market Size Of The Global Duchenne Muscular Dystrophy Market And Its Growth Rate?
The Duchenne Muscular Dystrophy Market demonstrates robust growth on account of advanced genetic understanding and clinical trials.
• 2024 Market Size: $1.16 billion
• 2025 Market Size: $1.26 billion (8.9% CAGR)
• 2029 Market Size: $1.75 billion (8.5% CAGR)
Notable growth can be attributed to emerging gene therapies, expanded access to therapies, and regulatory advancements.
What Is Driving The Growth In The Duchenne Muscular Dystrophy Market?
The escalating prevalence of chronic diseases is providing a significant impetus to the growth of the Duchenne muscular dystrophy market. Chronic diseases, which last for minimum a year, pose substantial health concerns and this genetic disorder, Duchenne muscular dystrophy, aids in addressing specific therapeutic needs of these patients highlighting the relevance of personalized medicine in curbing and potentially lessening the impact of chronic conditions. As per a report by the National Library of Medicine, by 2050, the number of people in the US aged 50 and older with at least one chronic condition is projected to rise to 142.66 million. Consequently, the burgeoning prevalence of chronic diseases is fueling the growth of the Duchenne muscular dystrophy market.
Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10368&type=smp
Who Are the Key Players Driving Duchenne Muscular Dystrophy Market Growth?
• Pfizer Inc.
• GlaxoSmithKline plc
• PerkinElmer Inc.
• BioMarin Pharmaceutical Inc.
• Sarepta Therapeutics Inc.
• PTC Therapeutics Inc.
• Asklepios BioPharmaceutical Inc.
• Catabasis Pharmaceuticals Inc.
• Wave Life Sciences Ltd.
• Bristol Myers Squibb Company
• BridgeBio Pharma Inc.
• Rocket Pharmaceuticals Inc.
• Italfarmaco SpA
• Solid Biosciences Inc.
• Avidity Biosciences Inc.
• Fulcrum Therapeutics Inc.
• Akashi Therapeutics Inc.
• WAVE Life Sciences Ltd.
• Capricor Therapeutics Inc.
• Santhera Pharmaceuticals Holding
• Armagen Technologies Inc.
• Dyne Therapeutics Inc.
• Benitec Biopharma Limited
• Edgewise Therapeutics Inc.
What Are The Key Trends In The Duchenne Muscular Dystrophy Market?
Notable trends include:
• Integration of digital health technologies
• Technological advancements in therapeutics
• Emergence of gene therapies and genetic medicines
• Regulatory support for orphan drugs
• Precision medicine approaches
What Are The Segments Of The Global Duchenne Muscular Dystrophy Market?
• By Therapy: Mutation Suppression, Exon Skipping Approach
• By Therapeutic Class: Molecular Based Therapies, Steroid Therapy
• By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
• By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
• By End User: Hospitals, Homecare, Specialty Clinics, Other End-Users
Which Region Leads The Duchenne Muscular Dystrophy Market?
In 2024, North America held the largest share in the Duchenne muscular dystrophy market. Anticipated to be the fastest-growing region, Asia-Pacific is predicted to display significant growth during the forecast period. The Duchenne muscular dystrophy market report provides an inclusive analysis of all key regions including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/duchenne-muscular-dystrophy-global-market-report
What Is Covered In The Duchenne Muscular Dystrophy Market Global Market Report?
- Market Size Analysis: Analyze the Duchenne Muscular Dystrophy Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Duchenne Muscular Dystrophy Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Duchenne Muscular Dystrophy Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Duchenne Muscular Dystrophy Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customise?id=10368&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
"Learn More About The Business Research Company
The Business Research Company offers comprehensive, data-rich research and insights. With over 15,000+ reports from 27 industries covering 60+ geographies and armed with 1,500,000 datasets, it thrives on in-depth secondary research and unique insights from industry leaders for informed decision-making. The Global Market Model (GMM) remains its premier market intelligence platform delivering comprehensive and updated forecasts."
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Duchenne Muscular Dystrophy Market: Promising Growth, Key Drivers and Current Trends Tracing a forecasted CAGR of 8.9% & 8.5% respectively in 2024-25 and 2025-29 periods. here
News-ID: 3840721 • Views: …
More Releases from The Business research company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Duchenne
Emerging Trends Influencing The Growth Of The Duchenne Muscular Dystrophy (DMD) …
The Duchenne Muscular Dystrophy (DMD) Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Expected to Be by 2034?
In recent times, the market size for Duchenne Muscular Dystrophy (DMD) therapeutics has seen a significant…
Rising Prevalence Of Chronic Diseases Fuels Growth In The Duchenne Muscular Dyst …
What industry-specific factors are fueling the growth of the duchenne muscular dystrophy market?
The rise in chronic diseases is projected to stimulate the expansion of the Duchenne muscular dystrophy market in the coming years. Chronic diseases are health complications that endure for a minimum of a year. Duchenne muscular dystrophy is instrumental in the increase of chronic diseases as it addresses the unique therapeutic requirements of those suffering from this genetic…
Shaping the Duchenne Muscular Dystrophy (DMD) Therapeutics Market in 2025: Bit B …
How Big Is the Duchenne Muscular Dystrophy (DMD) Therapeutics Market Expected to Be, and What Will Its Growth Rate Be?
The Duchenne muscular dystrophy (DMD) therapeutics market will grow from $11.95 billion in 2024 to $16.45 billion in 2025, at a CAGR of 37.6%. The growth is attributed to the increasing prevalence of Duchenne muscular dystrophy, rising awareness of treatment options, healthcare spending, and government initiatives.
The Duchenne muscular dystrophy (DMD) therapeutics…
Duchenne Muscular Dystrophy Pipeline Outlook Report 2024
DelveInsight's, "Duchenne Muscular Dystrophy Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Duchenne Muscular Dystrophy pipeline landscape. It covers the Duchenne Muscular Dystrophy pipeline drug profiles, including Duchenne Muscular Dystrophy clinical trials and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
…
Duchenne Muscular Dystrophy Treatmcent Market
Global Duchenne Muscular Dystrophy Treatmcent Market Set for Robust Growth During Forecast Period
The global Duchenne Muscular Dystrophy Treatment Market is poised to witness significant growth at a high Compound Annual Growth Rate (CAGR) during the forecast period of 2023 to 2030. Duchenne muscular dystrophy (DMD) stands as a genetic disorder marked by progressive muscle degeneration and weakness, with therapeutics aimed at addressing the absence of dystrophin, a crucial protein in…
Duchenne Muscular Dystrophy (DMD) Drugs Market Report
As per the research conducted by GME, the Duchenne Muscular Dystrophy (DMD) Drugs Market will grow with a CAGR value of 41.3 percent by 2026. The global market for Duchenne muscular dystrophy is foreseen to grow due to accelerated research and development activities, expanded patient awareness for effective treatments, and the launch of new medications Moreover, the disease's increasing prominence is likely to drive the global duchenne muscular dystrophy market…
